Quest Diagnostics Incorporated

Healthcare · Diagnostics & Research

246.50$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Quest Diagnostics Incorporated (DGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 16,939 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DGX
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	13,482	14,022	13,954	13,881	16,095	16,153	15,797	15,969	16,197	16,225	16,673	16,939
Current Assets	1,815	2,372	2,228	2,017	2,623	2,392	2,075	2,198	2,407	2,378	2,566	2,844
Cash	143	686	474	271	764	549	188	319	432	420	393	626
Cash & Short-Term Investments	143	686	474	271	764	549	188	319	432	420	393	626
Receivables	1,281	1,210	1,322	1,319	1,376	1,304	1,404	1,419	1,456	1,408	1,587	1,666
Inventory	184	190	181	182	184	188	189	187	186	189	225	233
Property, Plant & Equipment	2,437	–	–	–	2,754	2,764	2,754	2,775	2,794	2,860	–	–
Goodwill	7,732	7,733	7,830	7,885	8,605	8,856	8,849	8,883	8,901	8,945	9,120	9,112
Intangible Assets	1,219	1,166	1,192	1,202	1,716	1,763	1,725	1,706	1,662	1,636	1,717	1,672
Total Liabilities	6,943	7,604	7,408	7,146	9,174	9,257	8,754	8,623	8,821	8,939	9,007	9,120
Current Liabilities	1,618	1,815	2,298	2,012	2,092	2,169	1,441	2,024	2,134	2,278	2,177	1,788
Short-Term Debt	461	456	1,059	765	779	775	174	675	677	678	677	190
Accounts Payable	1,143	1,354	1,192	1,203	1,269	1,389	1,247	1,309	1,457	1,600	1,500	–
Long-Term Debt	3,946	4,410	3,804	3,816	5,648	5,615	5,858	5,169	5,171	5,167	5,155	5,632
Shareholders' Equity	6,425	6,307	6,432	6,617	6,809	6,778	6,929	7,228	7,258	7,170	7,366	7,516
Retained Earnings	8,711	8,825	8,935	9,080	9,222	9,360	9,490	9,682	9,837	9,994	10,151	10,374
Shares Outstanding	114	113	112	112	113	113	113	113	113	112	112	112

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings